The US organ transplant system might face an overhaul in a proposal to be announced on Wednesday after years of criticism; the FDA may decide whether to approve additional COVID-19 booster vaccinations for vulnerable populations; a new study finds the same, small breast cancer risk in multiple forms of hormonal birth control.
Read More
Dr Kashyap Patel Highlights COA's Focus at 2023 Community Oncology Conference
March 22nd 2023Kashyap Patel, MD, immediate past president of Community Oncology Alliance (COA) and CEO of Carolina Blood and Cancer Care Associates, talks about bringing together different stakeholders in the oncology space in order to benefit patients and providers.
Read More
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More
Kentucky passes a bill to require insurers to cover biomarker tests for patients with cancer; CDC opioid guidelines updated in November may be too late for patients with chronic pain; the Environmental Protection Agency is proposing new limits to reduce dangerous human-manufactured chemicals in drinking water.
Read More
The US Department of Veterans Affairs (VA) will cover Alzheimer drug lecanemab (Leqembi) based on inclusion criteria approval and other factors; Pfizer Inc. will buy drug maker Seagen Inc. and their targeted cancer drugs for $43 billion; Novo Nordisk will reduce its insulin costs by up to 75%, and also plans to discount other drugs.
Read More
Using Technology to Improve Patient Outcomes in Diabetes, Hypoglycemia
March 9th 2023Given the cost and impact of chronic diseases on the US health care system, health technology like digital coaching for chronic diseases is increasingly being looked at as a way to offer personalized therapies on a wide scale.
Read More
US adults had low trust in public health agency information during the COVID-19 pandemic, a new survey reported; a new study showed that people who have been incarcerated are more likely to die when they have cancer, compared to those never incarcerated; an unproven drug aimed at preventing preterm birth will be removed from the US market.
Read More
President Joe Biden proposes plan to tackle Medicare funding situation, testing GOP; WeightWatchers is in the process of buying telehealth company Sequence that will allow weight-loss drugs like Ozempic to be prescribed; patients experiencing long COVID-19 seem to be more likely to have gastrointestinal (GI) issues, finds a study.
Read More
What We’re Reading: Rare Disease Drug Approved; Congress and PBMs; FDA Panel Splits on RSV Shot
March 1st 2023The FDA approved the first drug for the rare disease Friedreich’s ataxia; House Republicans seek information from pharmacy benefit managers (PBMs); FDA panel narrowly supports respiratory syncytial virus (RSV) vaccine for older adults.
Read More